Figure 3.
Cumulative incidence of the introduction of systemic chemotherapy for training and validation samples-B. (A) Time from the diagnosis to introduction of systemic chemotherapy, according to the simplified iATL-PI. (B) Time from the diagnosis to introduction of systemic chemotherapy according to Shimoyama’s classification (ie, favorable/unfavorable chronic types and smoldering type).

Cumulative incidence of the introduction of systemic chemotherapy for training and validation samples-B. (A) Time from the diagnosis to introduction of systemic chemotherapy, according to the simplified iATL-PI. (B) Time from the diagnosis to introduction of systemic chemotherapy according to Shimoyama’s classification (ie, favorable/unfavorable chronic types and smoldering type).

Close Modal

or Create an Account

Close Modal
Close Modal